Ligand Pharmaceuticals Incorporated【LGND】 純利益の推移
機能の使い方
|
（単位：千ドル）
|
純利益
|
前年比（％）
|
|
4Q25
|
44,784
|
-244.1%
|
|
3Q25
|
117,273
|
-1735.2%
|
|
2Q25
|
4,847
|
-109.3%
|
|
1Q25
|
-42,451
|
-149.3%
|
|
4Q24
|
-31,088
|
-270.9%
|
|
3Q24
|
-7,172
|
-30.2%
|
|
2Q24
|
-51,911
|
-2366.9%
|
|
1Q24
|
86,139
|
+105.3%
|
|
4Q23
|
18,188
|
-204.0%
|
|
3Q23
|
-10,273
|
-2642.8%
|
|
2Q23
|
2,290
|
-355.9%
|
|
1Q23
|
41,949
|
-372.7%
|
|
4Q22
|
-17,485
|
+222.8%
|
|
3Q22
|
404
|
-97.1%
|
|
2Q22
|
-895
|
-102.9%
|
|
1Q22
|
-15,385
|
-185.0%
|
|
4Q21
|
-5,416
|
-194.0%
|
|
3Q21
|
13,723
|
-304.8%
|
|
2Q21
|
30,725
|
+39.1%
|
|
1Q21
|
18,106
|
-175.0%
|
|
4Q20
|
5,761
|
-178.2%
|
|
3Q20
|
-6,701
|
-56.1%
|
|
2Q20
|
22,086
|
-253.2%
|
|
1Q20
|
-24,131
|
-103.6%
|
|
4Q19
|
-7,365
|
+5.1%
|
|
3Q19
|
-15,251
|
-122.6%
|
|
2Q19
|
-14,419
|
-119.7%
|
|
1Q19
|
666,337
|
+1371.6%
|
|
4Q18
|
-7,007
|
-0.0%
|
|
3Q18
|
67,362
|
+699.2%
|
|
2Q18
|
73,162
|
+1107.7%
|
|
1Q18
|
45,279
|
+791.5%
|
|
4Q17
|
-7,007
|
+124.2%
|
|
3Q17
|
8,429
|
+702.0%
|
|
2Q17
|
6,058
|
-205.1%
|
|
1Q17
|
5,079
|
-23.1%
|
|
4Q16
|
-3,125
|
-137.0%
|
|
3Q16
|
1,051
|
-99.5%
|
|
2Q16
|
-5,763
|
-124.5%
|
|
1Q16
|
6,608
|
+776.4%
|
|
4Q15
|
8,448
|
+19.7%
|
|
3Q15
|
224,539
|
+17442.1%
|
|
2Q15
|
23,564
|
+1380.2%
|
|
1Q15
|
754
|
-64.0%
|
|
4Q14
|
7,055
|
+277.5%
|
|
3Q14
|
1,280
|
-34.9%
|
|
2Q14
|
1,592
|
-73.9%
|
|
1Q14
|
2,097
|
+40.3%
|
|
4Q13
|
1,869
|
+75.8%
|
|
3Q13
|
1,965
|
-1112.9%
|
|
2Q13
|
6,091
|
-368.7%
|
|
1Q13
|
1,495
|
+8.0%
|
|
4Q12
|
1,063
|
-80.7%
|
|
3Q12
|
-194
|
-95.0%
|
|
2Q12
|
-2,267
|
+148.0%
|
|
1Q12
|
1,384
|
-
|
|
4Q11
|
5,502
|
-
|
|
3Q11
|
-3,906
|
-
|
|
2Q11
|
-914
|
-
|